• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Pfizer CEO Expects Pivotal Coronavirus Vaccine Data in October

cafead

Administrator
Staff member
  • cafead   Sep 04, 2020 at 10:32: AM
via Albert Bourla, the CEO of Pfizer (NYSE:pFE), raised a lot of eyebrows on Thursday morning during a press briefing with biopharmaceutical industry executives leading efforts to develop vaccines and treatments to help mitigate the COVID-19 pandemic.

article source